GRDN
Guardian Pharmacy Services Inc

69
Mkt Cap
$2.11B
Volume
683,530.00
52W High
$37.43
52W Low
$19.17
PE Ratio
42.84
GRDN Fundamentals
Price
$33.27
Prev Close
$33.51
Open
$34.52
50D MA
$31.88
Beta
0.80
Avg. Volume
178,624.76
EPS (Annual)
$0.7776
P/B
10.24
Rev/Employee
$402,412.50
$1,895.88
Loading...
Loading...
News
all
press releases
Oppenheimer Issues Positive Forecast for Guardian Pharmacy Services (NYSE:GRDN) Stock Price
Oppenheimer raised their target price on Guardian Pharmacy Services from $35.00 to $38.00 and gave the stock an "outperform" rating in a research report on Thursday...
MarketBeat·19h ago
News Placeholder
More News
News Placeholder
Guardian Pharmacy Services Q4 Earnings Call Highlights
Guardian Pharmacy Services (NYSE:GRDN) reported fourth-quarter and full-year 2025 results that management said exceeded expectations, driven by continued resident growth, higher script volumes...
MarketBeat·2d ago
News Placeholder
Guardian Pharmacy Services (GRDN) Surpasses Q4 Earnings and Revenue Estimates
Guardian Pharmacy (GRDN) delivered earnings and revenue surprises of +37.04% and +2.41%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2d ago
News Placeholder
Guardian Pharmacy Services (NYSE:GRDN) Announces Earnings Results
Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) announced its quarterly earnings results on Wednesday. The company reported $0.37 earnings per share for the quarter, beating the consensus...
MarketBeat·2d ago
News Placeholder
Guardian Pharmacy Services Reports Fourth Quarter and Full Year 2025 Financial Results; Raises 2026 Adjusted EBITDA Guidance
Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ('LTC') pharmacy services companies, announced today its financial results for the fourth quarter and full...
Business Wire·2d ago
News Placeholder
Guardian Pharmacy Services, Inc. to Participate in Upcoming Oppenheimer Healthcare MedTech & Services Conference
Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that the company will participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference. Fred Burke, President and...
Business Wire·3d ago
News Placeholder
ARS Pharmaceuticals, Inc. (SPRY) Reports Q4 Loss, Beats Revenue Estimates
ARS Pharmaceuticals, Inc. (SPRY) delivered earnings and revenue surprises of -0.96% and +9.10%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4d ago
News Placeholder
All You Need to Know About Guardian Pharmacy (GRDN) Rating Upgrade to Buy
Guardian Pharmacy (GRDN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·8d ago
News Placeholder
Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Consensus Rating of "Moderate Buy" by Brokerages
Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five research firms that are currently covering the company...
MarketBeat·8d ago
News Placeholder
Guardian Pharmacy Services (GRDN) to Release Quarterly Earnings on Wednesday
Guardian Pharmacy Services (NYSE:GRDN) will be releasing its Q4 2025 earnings after the market closes on Wednesday, March 11. (View Earnings Report at...
MarketBeat·9d ago
<
1
2
...
>

Latest GRDN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.